![](/img/cover-not-exists.png)
The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy
Furubayashi, Nobuki, Negishi, Takahito, Yamashita, Takuya, Kusano, Shuhei, Taguchi, Kenichi, Shimokawa, Mototsugu, Nakamura, MotonobuLanguage:
english
Journal:
Molecular and Clinical Oncology
DOI:
10.3892/mco.2017.1452
Date:
October, 2017
File:
PDF, 301 KB
english, 2017